Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours.
Sears H F, Atkinson B, Mattis J, +5 more·Lancet (London, England)
A phase-I clinical trial of a murine monoclonal antibody that specifically suppresses growth of human gastrointestinal tumours in athymic mice was conducted in four patients, who were given 15-200 mg purified antibody. The monoclonal antibody persisted in the circulation for more than a week when more than 15 mg was gi…